CS Diagnostics Corp. (CSDX)

CS Diagnostics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2009	FY 2008
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2009	Dec 31, 2008
Cash & Equivalents	0.01	0	0.02	0.04	0.04
Cash & Short-Term Investments	0.01	0	0.02	0.04	0.04
Cash Growth	1259.88%	-97.54%	-45.52%	-0.01%	-0.27%
Other Current Assets	0.08	-	-	-	-
Total Current Assets	0.09	0	0.02	0.04	0.04
Property, Plant & Equipment	-	-	-	0.02	0.02
Other Intangible Assets	499.4	499.4	499.4	-	-
Total Assets	499.49	499.4	499.42	0.06	0.06
Accounts Payable	0.02	0	0.01	1.15	0.85
Accrued Expenses	-	-	-	0.72	0.75
Total Current Liabilities	0.02	0	0.01	1.87	1.6
Total Liabilities	0.02	0	0.01	1.87	1.6
Common Stock	0	0	0	0.05	0.05
Additional Paid-In Capital	504.16	504.16	504.17	4.13	4.13
Retained Earnings	-4.7	-4.77	-4.77	-5.99	-5.72
Comprehensive Income & Other	-	-0	-	-	-
Total Common Equity	499.47	499.4	499.41	-1.81	-1.54
Shareholders' Equity	499.47	499.4	499.41	-1.81	-1.54
Total Liabilities & Equity	499.49	499.4	499.42	0.06	0.06
Net Cash (Debt)	0.01	0	0.02	0.04	0.04
Net Cash Growth	1259.88%	-97.54%	-45.52%	-0.01%	-
Net Cash Per Share	0.00	-	0.00	0.39	0.39
Filing Date Shares Outstanding	249.99	137.34	110.79	0.1	0.1
Total Common Shares Outstanding	249.99	137.29	110.79	0.1	0.1
Working Capital	0.07	-0	0.01	-1.84	-1.57
Book Value Per Share	2.00	3.64	4.51	-18.79	-15.99
Tangible Book Value	0.07	-0	0.01	-1.81	-1.54
Tangible Book Value Per Share	0.00	-0.00	0.00	-18.79	-15.99

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.